Publication: Double check up of malignancy biopsy specimens for patient safety
Submitted Date
Received Date
Accepted Date
Issued Date
2010-11-01
Copyright Date
Announcement No.
Application No.
Patent No.
Valid Date
Resource Type
Edition
Resource Version
Language
File Type
No. of Pages/File Size
ISBN
ISSN
01252208
01252208
01252208
eISSN
DOI
Scopus ID
WOS ID
Pubmed ID
arXiv ID
Call No.
Other identifier(s)
2-s2.0-78649261818
Journal Title
Volume
Issue
item.page.oaire.edition
Start Page
End Page
Access Rights
Access Status
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Physical Location
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol.93, No.11 (2010), 1310-1316
Citation
Pattana Sornmayura, Yingluck Visessiri, Mana Rochanawutanon, Vorachai Sirikulchayanonta, Rangsima Aroonroch, Wasana Kanoksil, Noppadol Larbcharoensub, Sansanee Wongwaisayawan, Juvady Leopairut, Panas Chalermsanyakorn, Suchin Worawichawong, Niramol Chanplakorn, Paisan Leelachaikul, Atcharaporn Pongtippan (2010). Double check up of malignancy biopsy specimens for patient safety. Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/29462.
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Double check up of malignancy biopsy specimens for patient safety
Alternative Title(s)
Author(s)
Author's Affiliation
Author's E-mail
Editor(s)
Editor's Affiliation
Corresponding Author(s)
Creator(s)
Compiler
Advisor(s)
Illustrator(s)
Applicant(s)
Inventor(s)
Issuer
Assignee
Other Contributor(s)
Series
Has Part
Abstract
Background: The diagnostic of malignancy in biopsy specimens is very important because it guides to selected treatment option and prognostic prediction. However, biopsy specimens usually have small pieces leading to variations of the interpretation by anatomical pathologists. Objective: To detect and correct the errors or the significant discrepancies in the diagnosis of biopsy specimens before signout and to determine the frequency of anatomic pathology significant discrepancies. Design: The application of the mutually agreed work instructions (record) for the detection of errors or the significant discrepancies and their process of sign-out. The record of biopsy specimen that received a secondary check (1,959 cases, 2005-2007) was analyzed. Results: After a secondary check, 53 cases of non-malignancy for any reason by a second pathologist were included. However, when using our definition on significant discrepancies, only 37 cases were considered. Another seven cases with the opinions with malignancy that were of different cell types that do harm to the patients were added. Therefore, 44 cases (2.25%) had truly significant discrepancies. Conclusion: The truly significant discrepancy frequency was 2.25% during the process of pre-sign-out secondary check of malignancy of biopsy specimens. The project has been applied as a routine daily work. It can be an innovative safety program for patient in Thailand.